Načítá se...
SGLT2 inhibition in the diabetic kidney – an update
PURPOSE OF REVIEW: The sodium glucose cotransporter SGLT2 reabsorbs most of the glucose filtered by the kidneys. SGLT2 inhibitors reduce glucose reabsorption thereby lowering blood glucose levels and have been approved as new anti-hyperglycemic drugs. While the therapeutic strategy is very promising...
Uloženo v:
| Vydáno v: | Curr Opin Nephrol Hypertens |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4703043/ https://ncbi.nlm.nih.gov/pubmed/26575393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MNH.0000000000000187 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|